etanercept

Ligand id: 6789

Name: etanercept

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: etanercept

Classification
Compound class Antibody
Approved drug? Yes (FDA (1998), EMA (2009))
International Nonproprietary Names
INN number INN
7783 etanercept
Synonyms
Enbrel® | Rhu Tnfr:Fc | TNFR-Fc | TNR 001
Comments
Etanercept is a TNFα inhibitor. It is a dimeric recombinant protein fusing the TNF receptor 2 (TNFRSF1B) to the Fc region of the human IgG1 antibody. Etanercept is used as a disease-modifying anti-rheumatic drug (DMARD).

Biosimilars:
NameTrade nameCompanyClinical PhaseIndicationsReferences
Etanercept-szzsErelziSandozApproved (1998 FDA, 2009 EMA)As per reference agent 
SB4Brenzys; BenepaliSamsung BioepisApproved in S Korea, Canada and EuropeAs per reference agent 
 LifmiorPfizerApproved (2017 EMA)As per reference agent 
ENIA11; TuNEX; OpinerceptMycenax BiotechApproved (2018 Taiwan)Rheumatoid arthritisReuters news brief
EtaceptReumatoceptShanghai CP GoujianMarketed in Colombia as Etanar Rheumatoid arthritis 
CHS-0214 Coherus BiosciencesPh 3 (NCT02134210)Plaque psoriasis 
LBEC0101 LG Life SciencesPh 3 (NCT02357069)Rheumatoid arthritis[3-4]
Database Links
Specialist databases
IMGT/mAb-DB 216
Other databases
CAS Registry No. 185243-69-0
ChEMBL Ligand CHEMBL1201572
DrugBank Ligand DB00005
GtoPdb PubChem SID 178103395
PubChem SID 135343504
Search PubMed clinical trials etanercept
Search PubMed titles etanercept
Search PubMed titles/abstracts etanercept
Wikipedia Etanercept